What does CUSIP 92243G108 represent in this 13F holders report?

CUSIP 92243G108 is the security identifier for PCVX - Vaxcyte, Inc. - Common Stock, $0.001 par value per share used to aggregate holder disclosures.

How many institutions held PCVX - Vaxcyte, Inc. - Common Stock, $0.001 par value per share in Q4 2022?

197 institutional investors reported PCVX - Vaxcyte, Inc. - Common Stock, $0.001 par value per share for Q4 2022. Use the holders table for investor-level position and value details.

Vaxcyte, Inc. - Common Stock, $0.001 par value per share (PCVX)

CUSIP: 92243G108

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class: Equity / Common Stock, $0.001 par value per share
Shares outstanding: 145,782,011
Total 13F shares: 81,609,487
Share change: +23,689,419
Total reported value: $3,913,093,743
Put/Call ratio: 65%
Price per share: $47.95
Number of holders: 197
Value change: +$1,140,362,544
Number of buys: 170
Number of sells: 29

Quarterly Holders Quick Answers

What is CUSIP 92243G108?
CUSIP 92243G108 identifies PCVX - Vaxcyte, Inc. - Common Stock, $0.001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2023
Previous quarter: Q3 2022

Recent filing periods for CUSIP 92243G108:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of PCVX - Vaxcyte, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	6.1%	8,897,197	$213,533,000	—	30 Sep 2022	13F
RA CAPITAL MANAGEMENT, L.P.	13F	Company	3.1%	4,581,203	$109,949,000	—	30 Sep 2022	13F
JANUS HENDERSON GROUP PLC	13F	Company	3.1%	4,537,751	$108,908,000	—	30 Sep 2022	13F
VANGUARD GROUP INC	13F	Company	3.1%	4,452,145	$106,851,000	—	30 Sep 2022	13F
Abingworth LLP	13F	Company	2.9%	4,168,718	$100,049,000	—	30 Sep 2022	13F
BlackRock Finance, Inc.	13F	Company	2.4%	3,492,321	$83,817,000	—	30 Sep 2022	13F
TPG GP A, LLC	13F	Company	2.3%	3,285,504	$78,852,000	—	30 Sep 2022	13F
STATE STREET CORP	13F	Company	1.4%	1,993,036	$47,833,000	—	30 Sep 2022	13F
Medicxi Ventures Management (Jersey) Ltd	13F	Company	1.3%	1,887,478	$45,299,000	—	30 Sep 2022	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	1.2%	1,748,921	$41,974,000	—	30 Sep 2022	13F
Frazier Life Sciences Management, L.P.	13F	Company	1.1%	1,547,405	$37,138,000	—	30 Sep 2022	13F
Jeff Fairman	3/4/5	VP, Research	— mixed-class rows	369,054 mixed-class rows	$22,935,618	—	30 Dec 2022	3/4/5
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.61%	894,786	$21,474,000	—	30 Sep 2022	13F
NATIONAL BANK OF CANADA /FI/	13F	Company	0.61%	885,538	$21,259,000	—	30 Sep 2022	13F
CITADEL ADVISORS LLC	13F	Company	0.57%	832,867	$19,989,000	—	30 Sep 2022	13F
Novo Holdings A/S	13F	Company	0.57%	823,705	$19,769,000	—	30 Sep 2022	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.54%	786,322	$18,872,000	—	30 Sep 2022	13F
Pivotal bioVenture Partners Investment Advisor LLC	13F	Company	0.53%	776,039	$18,625,000	—	30 Sep 2022	13F
ORBIMED ADVISORS LLC	13F	Company	0.49%	717,900	$17,230,000	—	30 Sep 2022	13F
Kynam Capital Management, LP	13F	Company	0.48%	698,638	$16,767,000	—	30 Sep 2022	13F
Avidity Partners Management LP	13F	Company	0.43%	628,700	$15,089,000	—	30 Sep 2022	13F
GREAT POINT PARTNERS LLC	13F	Company	0.41%	600,000	$14,400,000	—	30 Sep 2022	13F
DRIEHAUS CAPITAL MANAGEMENT LLC	13F	Company	0.4%	583,606	$14,007,000	—	30 Sep 2022	13F
Capital Research Global Investors	13F	Company	0.35%	514,856	$12,679,000	—	30 Sep 2022	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.33%	487,883	$11,709,000	—	30 Sep 2022	13F
NORTHERN TRUST CORP	13F	Company	0.33%	483,892	$11,613,000	—	30 Sep 2022	13F
Point72 Asset Management, L.P.	13F	Company	0.29%	422,800	$10,147,000	—	30 Sep 2022	13F
Vivo Capital, LLC	13F	Company	0.28%	404,508	$9,708,000	—	30 Sep 2022	13F
Ghost Tree Capital, LLC	13F	Company	0.25%	360,000	$8,640,000	—	30 Sep 2022	13F
Polar Asset Management Partners Inc.	13F	Company	0.24%	355,700	$8,537,000	—	30 Sep 2022	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.24%	345,226	$8,286,000	—	30 Sep 2022	13F
Soleus Capital Management, L.P.	13F	Company	0.23%	335,650	$8,056,000	—	30 Sep 2022	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.17%	247,329	$5,936,000	—	30 Sep 2022	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.16%	237,433	$5,698,000	—	30 Sep 2022	13F
Woodline Partners LP	13F	Company	0.13%	196,429	$4,714,000	—	30 Sep 2022	13F
Opaleye Management Inc.	13F	Company	0.13%	190,000	$4,560,000	—	30 Sep 2022	13F
Nuveen Asset Management, LLC	13F	Company	0.13%	189,512	$4,548,000	—	30 Sep 2022	13F
JPMORGAN CHASE & CO	13F	Company	0.12%	180,127	$4,322,000	—	30 Sep 2022	13F
Bank of New York Mellon Corp	13F	Company	0.12%	179,570	$4,310,000	—	30 Sep 2022	13F
CITIGROUP INC	13F	Company	0.11%	155,426	$3,730,000	—	30 Sep 2022	13F
MOORE CAPITAL MANAGEMENT, LP	13F	Company	0.1%	143,966	$3,455,000	—	30 Sep 2022	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.07%	106,454	$2,556,000	—	30 Sep 2022	13F
Ensign Peak Advisors, Inc	13F	Company	0.07%	103,575	$2,486,000	—	30 Sep 2022	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	0.07%	100,000	$2,400,000	—	30 Sep 2022	13F
Rafferty Asset Management, LLC	13F	Company	0.06%	93,413	$2,242,000	—	30 Sep 2022	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.06%	93,200	$2,237,000	—	30 Sep 2022	13F
ACUTA CAPITAL PARTNERS, LLC	13F	Company	0.06%	85,000	$2,040,000	—	30 Sep 2022	13F
Swiss National Bank	13F	Company	0.06%	83,000	$1,992,000	—	30 Sep 2022	13F
Tri Locum Partners LP	13F	Company	0.05%	79,411	$1,906,000	—	30 Sep 2022	13F
RHUMBLINE ADVISERS	13F	Company	0.05%	68,230	$1,638,000	—	30 Sep 2022	13F

Institutional Holders of Vaxcyte, Inc. - Common Stock, $0.001 par value per share (PCVX) as of Q4 2022

As of 31 Dec 2022, Vaxcyte, Inc. - Common Stock, $0.001 par value per share (PCVX) was held by 197 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 81,609,487 shares. The largest 10 holders included FMR LLC, VANGUARD GROUP INC, JANUS HENDERSON GROUP PLC, RA CAPITAL MANAGEMENT, L.P., BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, Capital Research Global Investors, Abingworth LLP, and Avidity Partners Management LP. This page lists 197 institutional shareholders reporting positions in this security for the Q4 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2022 vs Q3 2022 Across Filers

Q3 2022 holders

121

Q4 2022 holders

197

Holder diff

Investor	Q3 2022 Shares	Q4 2022 Shares	Share Diff	Share Chg %	Q3 2022 Value $	Q4 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.